The researchers found an impressive increase in the number of new blood vessels in the brains of mice receiving this treatment, compared to controls, as confirmed by CD31 immunohistochemistry (IHC) in the ischemic stroke brains. This evidence concerns the gene PECAM1 and ischemic stroke.